Pharmacological treatment of neuropathic pain in older persons

Clinical Interventions in Aging

Volumn 3, Issue 1, 2008, Pages 111-120

  Haslam, Clair ^a   Nurmikko, Turo ^b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anticonvulsants; Antidepressants; Capsaicin; Elderly; Lidocaine patch plaster; Neuropathic pain; Opioids; Tramadol

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CANNABINOID DERIVATIVE; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; DULOXETINE; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; MEXILETINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OXCARBAZEPINE; PARACETAMOL PLUS TRAMADOL; PAROXETINE; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

AGRANULOCYTOSIS; ANALGESIC ACTIVITY; ANOREXIA; ANTICHOLINERGIC EFFECT; APLASTIC ANEMIA; BLOOD PRESSURE; BODY WEIGHT; BONE MARROW TOXICITY; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; CONVULSION; DAILY LIFE ACTIVITY; DEPRESSION; DIABETIC NEUROPATHY; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FATALITY; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; EPILEPSY; GUILLAIN BARRE SYNDROME; HEART RATE; HUMAN; HYPONATREMIA; HYPOTENSION; LIVER TOXICITY; LOW DRUG DOSE; MOOD; NAUSEA; NEUROPATHIC PAIN; PHANTOM PAIN; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; RECOMMENDED DRUG DOSE; REVIEW; SEDATION; SEROTONIN SYNDROME; SIDE EFFECT; SKIN BURNING SENSATION; SKIN MANIFESTATION; SOCIAL INTERACTION; SOMNOLENCE; STOMACH PAIN; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT; URINE RETENTION; VOMITING;

AGED; AMINES; ANALGESICS, OPIOID; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; OSTEOARTHRITIS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; PRACTICE GUIDELINES AS TOPIC; SEROTONIN UPTAKE INHIBITORS; TRAMADOL;

EID: 42449120984     PISSN: 11769092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Antai-Otong D. 2006. Antidepressants in late-life depression: prescribing principles. Perspectives in Psychiatric Care, 42:149-53.
2. Attal N, Cruccu G, Haanpaa M, et al. 2006. EFNS guidelines on pharmacological treatment of neuropathic pain. European Journal of Neurology, 13:1153-69.
3. [ANZCA] Australian and New Zealand College of Anaesthetists. 2005. Acute pain management: scientific evidence. 2nd ed. Australia: National Health and Medical Research Council.
4. Baca E, Roca M, Garcia-Calvo C, et al. 2006. Venlafaxine extended-release in patients older than 80 years with depressive syndrome. International Journal of Geriatric Psychiatry, 21:337-43.
5. Bergey G. 2004. Initial treatment of epilepsy: special issues in treating the elderly. Neurology, 63:S40-8.
6. Bernstein J, Korman N, Bickers D, et al. 1989. Topical capsaicin treatment of chronic postherpetic; neuralgia. Journal of American Academy of Dermatology, 21:265-70.
7. Brodie M, Overstall P, Giorgi L. 1999. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Research, 37:81-7.
8. British National Formulary. 2007. BNF 53.
9. Budd K. 1999. The role of tramadol in acute pain management. Acute Pain, 2:189-96.
10. Burris J. 2004. Pharmacologic approaches to geriatric pain management. Archives of Physical Medicine and Rehabilitation, 85(Suppl 3):S45-9.
11. Carey T, Evans A, Hadler N, et al. 1996. Acute severe low back pain. A population-based study of prevalence and care-secking. Spine, 21:339-44.
12. Cusack B. 2004. Pharmacokinetics in Older Persons. The American Journal of Geriatric Pharmacotherapy, 2:274-302.
13. Daousi C, MacFarlane IA, Woodward A, et al. 2004. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diab Med, 21:976-82.
14. Duck P, Krtaz K, Karnes L, et al. 1993. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and neuropathy in a population-based cohort: The Rochester Diabetic Neunopathy Study. Neurology, 43:817-24.
15. Dworkin R, Backonja M, Rowbotham M. 2003. Advances in neuropathic pain: diagnosis, mechanisms and treatment recommendations. Archives of Neurology, 60:1524-34.
16. Dworkin RH, Corbin AE, Young JP, et al. 2003. Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology, 60:1274-83.
17. Ferrell B. 1995. Pain evaluation and management in the nursing home. Annals of Internal Medicine, 123:681-7.
18. Finnerup NB, Otto M, McQuay HJ, et al. 2005. Algorithm for neuropathic pain treatment: an evidence based approach. Pain, 118:289-305.
19. Gagliese L, Jackson M, Ritvo P, et al. 2000. Age is not an impediment to effective use of patient-controlled analgesia by surgical patients. Anesthesiology, 93:601-10.
20. Gammaitoni A, Alvarez N, Galer B. 2003. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. Journal of Clinical Pharmacology, 43:111-17.
21. Gimbel J, Richards P, Portenoy R. 2003. Controlled release oxycodone for pain in diabetic neuropathy. A randomisod controlled trial. Neurology, 60:927-34.
22. Giron M, Fastbom J, Winblad B. 2005. Clinical trials of potential antidepressants: to what extent are the elderly represented: a review. International Journal of Geriatric Psychiatry, 20:201-17.
23. Helme R, Gibson S. 1999. Chapter 8: pain it older people. In: Crombie I ed. Epidemiology of pain. Seattle: IASP Press. p 103-12.
24. Helme R, Gibson S. 2001. The epidemiology of pain in elderly people. Clinical Geriatric Medicine, 17:417-31.
25. International Association for the Study of Pain. 2006. Older people's pain. Pain Clinical Updates, 14:1-4.
26. Johnson S. 2007. Opioid safety in patients with renal or hepatic dysfunction. Pain treatment topics [online]. Accessed 1 June 2007. URL: http://www.pain-topics.org.
27. Leijon G, Boivie J. 1989. Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain, 36:27-36.
28. Leppik I. 2005. Choosing an antiepileptic: selectingdrugs for older patients with epilepsy. Geriatrics, 60(11):42-7.
29. Leppik I. 2006. Antiepileptic drug trials in the elderly. Epilepsy Research, 68:45-8.
30. Leppik I, Brodie M, Saetre E. 2006. Outcomes research: clinical trials in the elderly. Epilepsy Research, 68S:S71-6.
31. Loney P, Stratford P. 1999. The prevalence of low back pain in adults: a methodological review of the literature. Physical Therapy, 79:384-96.
32. Macintyre P, Jarvis D. 1996. Age is the best predictor of postoperative morphine requirement. Pain, 64:357-64.
33. Moulin DE, Clark AJ, Gilron I, et al. 2007. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage, 12:13-21.
34. Oaklander A, Rissmiller J. 2002. Post-herpetic neuralgia after shingles is an under-recognised cause of chronic vulvar pain. Obstetrics and Gynaecology, 99:625.
35. Parikh C. 2000. Antidepressants in the elderly: challenges for study design and their interpretation. British Journal of Clinical Pharmacology, 49:539-47.
36. Partanen J, Niakanen L, Lehiten J, et al. 1995. Nature history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. New England Journal of Medicine, 333:88-94.
37. Perucca E, Berlowitz D, Birnbaum A, et al. 2006. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Research, 68S:S49-63.
38. Raja SN, Haythornethwaite, Pappagallo M, et al. 2002. Opioid versus antidepressants in postherpetic neuralgia. A randomized controlled trial. Neurology, 59:1015-21.
39. Ray W, Meredith S, Thapa P, et al. 2004. Cyclic antidepressants and the risk ofsudden cardiac death. Clinical Pharmacology and Therapeutics, 75:234-41.
40. Rice ASC, Maton S. 2001. Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain, 94:215-24.
41. Rosenthal N, Silverfield J, Wu S, et al. 2004. Tramadol/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population. Journal of the American Geriatric Society, 52:374-80.
42. Rowan A, Ramsay R, Collins J, et al. 2005. VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomised study of gabapentin, lamotrigine, and carbamazepine. Neurology, 64:1868-73.
43. Rowbotham M, Harden N, Stacey B, et al. 1998. Gabapentin for the treatment of postherpetic neuralgia. JAMA, 280:1837-42.
44. Sabatowski R, Galvez R, Cherry DA, et al. 2004. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain, 109:26-35.
45. Schnitzer T. 1999. Managing chronic pain with tramadol in elderly patients. Clinical Geriatrics, 7(8).
46. Sindrup S. 2003. Chapter 18: Antidepressants and chronic pain. In: Jensen T, Wilson P, Rice A eds. Clinical pain management: chronic pain. London: Arnold.
47. Taylor R. 2006. Epidemiology of refractory neuropathic pain. Pain Practice, 6:22-6.
48. Treede R-D, Jensen TS, Campbell JN, et al. In press. Neuropathic pain: redefinition and a grading system for clinical and research diagnostic purposes. Neurology.
49. US Bureau of the Consensus 2002. International Database.
50. Watson C, Tyler K, Bickers D, et al. 1993. A randomised vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clinical Therapeutics, 15:510-26.
51. Watson C, Babul N. 1998. Efficacy of oxycodone in neuropathic pain. A randomized trial in postherpetic neuralgia. Neurology, 50:1837-41.
52. Watson C, Moulin D, Watt-Watson J, et al. 2003. Controlled-release oxycodone relieves neuropathic pain: a randomised controlled trial in painful diabetic neuropathy. Pain, 105:71-8.
53. Won A, Lapane K, Vallow S, et al. 2006. Long-term effects of analgesics in a population of elderly nursing home residents with persistent non-malignant pain. The Journals of Gerontology, 61A:165-9.
54. Woodhouse A, Mather L. 1997. The influence of age upon opioid use in the patient-controlled analgesia (PCA) environment. Anaesthesia, 52:949-55.